Search research articles
Contact Us
Filters
Showing results (451-460 of 493) with videos related to
Page
of 50
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 27, 2019
Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls
Ilir Agalliu, Roberto A Ortega, Marta San Luciano, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 20, 2016
Arm swing as a potential new prodromal marker of Parkinson's disease
Anat Mirelman, Hagar Bernad-Elazari, Avner Thaler, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 23, 2017
Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non-Ashkenazi Jewish ancestry
Annie J Lee, Yuanjia Wang, Roy N Alcalay, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 21, 2022
The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy
Gregor K Wenning, Iva Stankovic, Luca Vignatelli, et al.
Science Translational Medicine
|
February 21, 2012
Phosphorylated α-synuclein in Parkinson's disease
Yu Wang, Min Shi, Kathryn A Chung, et al.
Cell Stem Cell
|
March 12, 2013
Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression
Peter Reinhardt, Benjamin Schmid, Lena F Burbulla, et al.
Nature Communications
|
November 25, 2020
Common diseases alter the physiological age-related blood microRNA profile
Tobias Fehlmann, Benoit Lehallier, Nicholas Schaum, et al.
Journal of Parkinson'S Disease
|
June 4, 2025
Tackling gender in progressive supranuclear palsy: Male patients present more apathy
Lan Ye, Stephan Greten, Ida Wilkens, et al.
The Lancet. Neurology
|
July 7, 2019
Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial
Johannes Levin, Sylvia Maaß, Madeleine Schuberth, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 6, 2021
The Mutation Matters: CSF Profiles of GCase, Sphingolipids, α-Synuclein in PD<sub>GBA</sub>
Stefanie Lerche, Claudia Schulte, Isabel Wurster, et al.
Page
of 50
Search research articles
Search
Showing results (451-460 of 493) with videos related to
Sort By:
Page
of 50
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 27, 2019
Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls
Ilir Agalliu, Roberto A Ortega, Marta San Luciano, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 20, 2016
Arm swing as a potential new prodromal marker of Parkinson's disease
Anat Mirelman, Hagar Bernad-Elazari, Avner Thaler, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 23, 2017
Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non-Ashkenazi Jewish ancestry
Annie J Lee, Yuanjia Wang, Roy N Alcalay, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 21, 2022
The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy
Gregor K Wenning, Iva Stankovic, Luca Vignatelli, et al.
Science Translational Medicine
|
February 21, 2012
Phosphorylated α-synuclein in Parkinson's disease
Yu Wang, Min Shi, Kathryn A Chung, et al.
Cell Stem Cell
|
March 12, 2013
Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression
Peter Reinhardt, Benjamin Schmid, Lena F Burbulla, et al.
Nature Communications
|
November 25, 2020
Common diseases alter the physiological age-related blood microRNA profile
Tobias Fehlmann, Benoit Lehallier, Nicholas Schaum, et al.
Journal of Parkinson'S Disease
|
June 4, 2025
Tackling gender in progressive supranuclear palsy: Male patients present more apathy
Lan Ye, Stephan Greten, Ida Wilkens, et al.
The Lancet. Neurology
|
July 7, 2019
Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial
Johannes Levin, Sylvia Maaß, Madeleine Schuberth, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 6, 2021
The Mutation Matters: CSF Profiles of GCase, Sphingolipids, α-Synuclein in PD<sub>GBA</sub>
Stefanie Lerche, Claudia Schulte, Isabel Wurster, et al.
Page
of 50